LEIDOS BIOMEDICAL RESEARCH, INC. - Coronavirus Contracts

Contracts Vendors Agencies Categories States

Coronavirus Contracts

Tracking Federal Purchases to Fight the Coronavirus

Home › All Vendors › Vendor ›

LEIDOS BIOMEDICAL RESEARCH, INC.

Total Committed Value of Federal Contracts

$938M

Total Contracts

Total Actions

Location

Frederick, MD

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Description	Category	Agency	Signed	Amount Committed
THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS.	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	August 17, 2021	$24,886,601
NIAID VRC	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	July 15, 2021	$500,000
DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT AND PEDIATRIC PATIENTS WITH UNKNOWN FEBRILE ILLNESS FR	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	June 17, 2021	$8,758,455
NCI OPERATIONAL TASK ORDER	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	June 02, 2021	$2,626,906
NIAID DIR	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	May 20, 2021	$1,100,000
NIAID DCR OPERATIONAL TASK ORDER COVID FUNDING IN THE AMOUNT OF $3,706,224 FOR COVID RELATED EFFORTS ON THIS TASK ORDER	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	February 25, 2021	$0
CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET)	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	February 10, 2021	$86,551,385
COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	January 25, 2021	$0
NIAID COVID-19 ACTIV3	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	January 22, 2021	-$7,368,816
NCI FEDERALLY FUNDED RESEARCH AND DEVELOPMENT CENTER (FFRDC) CONTRACT	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	January 21, 2021	$1,283,576
NIAID DMID BIG EFFECT TRIAL (BET) - INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL TITLED A MULTICENTER PLATFORM EVALUATING PUTATIVE THERAPEUTICS FOR THE TREATMENT OF COVID-19 IN HOSPITALIZED ADULTS (SHORT TITLE,	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	January 15, 2021	$0
INITIATE THE MANAGEMENT, OVERSIGHT, AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL TITLED "A MULTICENTER, ADAPTIVE, RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19".	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	January 15, 2021	$25,075,500
NIAID DCR OPERATIONAL TASK ORDER COVID FUNDING IN THE AMOUNT OF $3,706,224 FOR COVID RELATED EFFORTS ON THIS TASK ORDER	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	January 13, 2021	$0
COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	November 23, 2020	$0
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19 (2,000 SUBJECTS	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	November 20, 2020	$0
NCI OPERATIONAL TASK ORDER	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	November 12, 2020	$400,000
PRE-CLINICAL ASSESSMENT OF MONOCLONAL ANTIBODIES AND OTHER PROMISING VACCINES/AGENTS	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	November 06, 2020	$0
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19 (2,000 SUBJECTS	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	October 27, 2020	$0
NIAID DCR OPERATIONAL COVID RELATED EFFORTS	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	October 27, 2020	$0
ON BEHALF OF DCR FACILITATE THE CONDUCT OF AN OBSERVATIONAL STUDY TO CHARACTERIZE PATIENTS WITH COVID-19 INFECTION (10,000 SUBJECTS).	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	October 27, 2020	$0
NIAID COVID-19 ACTIV3	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	October 22, 2020	$26,150,457
NCI OPERATIONAL TASK ORDER COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005 COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	October 13, 2020	$0
NCI OPERATIONAL TASK ORDER	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	September 27, 2020	$207,226,867
NIAID COVID-19 ACTIV3	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	September 01, 2020	$198,740,313
COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	September 01, 2020	$0
NIAID DCR OPERATIONAL TASK ORDER COVID FUNDING IN THE AMOUNT OF $3,706,224 FOR COVID RELATED EFFORTS ON THIS TASK ORDER	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	August 28, 2020	$68,909,533
NIAID DIR	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	August 25, 2020	$6,882,557
NCI OPERATIONAL TASK ORDER COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005 COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	August 21, 2020	$2,150,259
NCI OPERATIONAL TASK ORDER COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005 COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	August 18, 2020	$10,574,155
NCI OPERATIONAL TASK ORDER COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005 COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	August 14, 2020	$4,550,785
NIAID DMID BIG EFFECT TRIAL (BET) - INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL TITLED A MULTICENTER PLATFORM EVALUATING PUTATIVE THERAPEUTICS FOR THE TREATMENT OF COVID-19 IN HOSPITALIZED ADULTS (SHORT TITLE,	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	August 04, 2020	$14,320,095
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19 (2,000 SUBJECTS	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	July 30, 2020	$33,788,063
NCI OPERATIONAL TASK ORDER COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005 COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	July 27, 2020	$0
NCI OPERATIONAL TASK ORDER COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005 COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	July 17, 2020	$22,416,036
PROVIDE THE FULL RANGE OF SERVICES REQUIRED TO SUPPORT DCR IN ITS PROVISION OF SUPPORT SERVICES, OVERSIGHT, AND MANAGEMENT OF INTRAMURAL CLINICAL RESEARCH, PROGRAM PLANNING AND MANAGEMENT, REGULATORY MONITORING AND COMPLIANCE, STATISTICAL CONSULTATIO	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	July 08, 2020	$5,070,370
COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	July 08, 2020	$0
MANUFACTURE AND TESTING OF ZIKA VIRUS OR ZIKA-RELATED VIRUS VACCINE PRODUCTS. COVID-19: ALCOHOL-BASED HAND SANITIZER WILL BE MANUFACTURED AND MADE AVAILABLE BASED ON CURRENT FDA POLICY ISSUED EARLY MARCH AND UPDATED ON MARCH 27, 2020. THE HAND SA	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	July 01, 2020	$0
INITIATE THE MANAGEMENT, OVERSIGHT, AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL TITLED "A MULTICENTER, ADAPTIVE, RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19".	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	June 30, 2020	$23,414,109
COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	June 30, 2020	$50,000,000
NCI OPERATIONAL TASK ORDER COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005 COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	June 19, 2020	$46,000,000
ON BEHALF OF DCR FACILITATE THE CONDUCT OF AN OBSERVATIONAL STUDY TO CHARACTERIZE PATIENTS WITH COVID-19 INFECTION (10,000 SUBJECTS).	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	June 10, 2020	$7,568,588
PROVIDE THE FULL RANGE OF SERVICES REQUIRED TO SUPPORT DCR IN ITS PROVISION OF SUPPORT SERVICES, OVERSIGHT, AND MANAGEMENT OF INTRAMURAL CLINICAL RESEARCH, PROGRAM PLANNING AND MANAGEMENT, REGULATORY MONITORING AND COMPLIANCE, STATISTICAL CONSULTATIO	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	June 08, 2020	$0
NCI OPERATIONAL TASK ORDER COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005 COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	June 04, 2020	-$393,000
PROVIDE THE FULL RANGE OF SERVICES REQUIRED TO SUPPORT DCR IN ITS PROVISION OF SUPPORT SERVICES, OVERSIGHT, AND MANAGEMENT OF INTRAMURAL CLINICAL RESEARCH, PROGRAM PLANNING AND MANAGEMENT, REGULATORY MONITORING AND COMPLIANCE, STATISTICAL CONSULTATIO	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	May 27, 2020	$0
INITIATE THE MANAGEMENT, OVERSIGHT, AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL TITLED "A MULTICENTER, ADAPTIVE, RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19".	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	May 04, 2020	$10,104,139
NCI OPERATIONAL TASK ORDER COVID-19: INITIATE DCEG COVID-19 CASE STUDY: YT 20-144. PID # 600.129.20.01.018.001.0005 COVID-19: INITIATE DCEG COVID-19 CASE STUDY FOR CGR USE UNDER YT 20-144. PID # 600.129.20.01.038.001.0281	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	May 04, 2020	$0
NIAID DMID BIG EFFECT TRIAL (BET) - INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL TITLED A MULTICENTER PLATFORM EVALUATING PUTATIVE THERAPEUTICS FOR THE TREATMENT OF COVID-19 IN HOSPITALIZED ADULTS (SHORT TITLE,	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	May 01, 2020	$11,490,292
PROVIDE THE FULL RANGE OF SERVICES REQUIRED TO SUPPORT DCR IN ITS PROVISION OF SUPPORT SERVICES, OVERSIGHT, AND MANAGEMENT OF INTRAMURAL CLINICAL RESEARCH, PROGRAM PLANNING AND MANAGEMENT, REGULATORY MONITORING AND COMPLIANCE, STATISTICAL CONSULTATIO	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	April 10, 2020	$0
MANUFACTURE AND TESTING OF ZIKA VIRUS OR ZIKA-RELATED VIRUS VACCINE PRODUCTS. COVID-19: ALCOHOL-BASED HAND SANITIZER WILL BE MANUFACTURED AND MADE AVAILABLE BASED ON CURRENT FDA POLICY ISSUED EARLY MARCH AND UPDATED ON MARCH 27, 2020. THE HAND SA	Operation of Government Owned Contractor Operated R&D Facilities	National Institutes of Health	April 10, 2020	$0
ON BEHALF OF DCR FACILITATE THE CONDUCT OF AN OBSERVATIONAL STUDY TO CHARACTERIZE PATIENTS WITH COVID-19 INFECTION (10,000 SUBJECTS).	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	April 01, 2020	$4,926,752
INITIATE THE MANAGEMENT, OVERSIGHT, AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL TITLED "A MULTICENTER, ADAPTIVE, RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19".	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	April 01, 2020	$6,680,834
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19 (2,000 SUBJECTS	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	April 01, 2020	$33,571,749

See this vendor on usaspending.gov ›

About this data

This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.